Medicina, Dermatología y Toxicología
Departamento
Hospital Carlos III
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Hospital Carlos III (8)
2021
-
Demographic, clinical, and functional determinants of antithrombotic treatment in patients with nonvalvular atrial fibrillation
BMC Cardiovascular Disorders, Vol. 21, Núm. 1
2016
-
Association of triglycerides and new lipid markers with the incidence of hypertension in a Spanish cohort
Journal of Hypertension, Vol. 34, Núm. 7, pp. 1257-1265
-
Triglyceride-glucose index (TyG index) in comparison with fasting plasma glucose improved diabetes prediction in patients with normal fasting glucose: The Vascular-Metabolic CUN cohort
Preventive Medicine, Vol. 86, pp. 99-105
2015
-
Novedades cardiovasculares 2013/2014
Revista Clinica Espanola, Vol. 215, Núm. 1, pp. 33-42
2014
-
Unanswered clinical questions in the management of cardiometabolic risk in the elderly: A statement of the Spanish society of internal medicine
BMC Cardiovascular Disorders, Vol. 14, Núm. 1
2013
-
What was new about vascular risk in the year 2012?
Revista Clinica Espanola, Vol. 213, Núm. 9, pp. 442-452
2011
-
Pathogenesis of occult chronic hepatitis B virus infection
World Journal of Gastroenterology, Vol. 17, Núm. 12, pp. 1543-1548
2007
-
Prevalencia de enfermedad arterial periférica estimada mediante el índice tobillo-brazo en pacientes con síndrome metabólico. Estudio MERITO I
Revista Clinica Espanola, Vol. 207, Núm. 5, pp. 228-233